Valeant Pharmaceuticals Intl Inc (VRX): Amid Fraud Allegations And Sinking Stock Price, Four Big Questions Loom

A cloud of suspicion still hovers over Valeant Pharmaceuticals International Inc., but the company's top executives have a chance this week to shed light on internal processes that have raised allegations of fraud. The accusations, centered on the Canadian pharmaceutical giant's distribution and accounting model, sent the firm's share price tumbling by 35 percent last week. Monday, Valeant is hoping to dispel investors' doubts with a conference call set to begin before the U.S. equity market ope...